前收市價 | 257.40 |
開市 | 256.30 |
買盤 | 257.20 x 5000 |
賣出價 | 259.70 x 5000 |
今日波幅 | 256.30 - 256.30 |
52 週波幅 | 252.00 - 416.60 |
成交量 | |
平均成交量 | 8 |
市值 | 7.354B |
Beta 值 (5 年,每月) | 0.88 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -20.35 |
業績公佈日 | 2024年5月07日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 856.25 |
ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.
The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.
Bio-Rad's (BIO) margin performance bears the brunt of elevated raw material costs, increased logistics costs and higher employee-related expenses.